{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:36:06Z","timestamp":1781541366184,"version":"3.54.5"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p><jats:italic>Burkholderia cepacia<\/jats:italic> complex (Bcc) are typical objectionable microorganisms of concern for water-based pharmaceuticals. In order to achieve quick and effective detection of Bcc to prevent final product contamination, a new selective medium, <jats:italic>Burkholderia cepacia<\/jats:italic> complex selective agar (BCCSA), for the detection of Bcc in water-based pharmaceutical products was reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The formulation of BCCSA was optimized based on the carbon sources utilization of 60 Bcc strains from multiple origins. BCCSA and <jats:italic>Burkholderia cepacia<\/jats:italic> selective agar (BCSA), which was adopted in the examination chapter for Bcc in United States Pharmacopoeia (USP), were compared in terms of growth-promoting, indicative and inhibitory properties using Bcc and non-Bcc strains. In addition to streaking and spreading on solid media, this study determined the growth curves of Bcc strains in liquid culture systems to discuss the growth-promoting ability of the two selective media from both qualitative and quantitative perspectives. 168 strains of non-Bcc were streaked onto the two media to compare inhibitory capability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>\u03b1<\/jats:italic>-D-Lactose was unable to be utilized by all 60 test Bcc strains, while Sucrose was used by some Bcc strains, hence the carbon source composition of the medium BCCSA was adjusted by replacing lactose with sodium pyruvate and reducing the amount of sucrose added. The initial pH value of the medium was set as 6.2\u202f\u00b1\u202f0.2 at 25\u00b0C by adding potassium dihydrogen phosphate, taking into account the indication range of phenol red. The recovery of 16 Bcc standard strains on BCCSA showed no statistically significant difference compared to TSA (<jats:italic>p<\/jats:italic>\u202f=\u202f0.68), whereas BCSA demonstrated a significant reduction (<jats:italic>p<\/jats:italic>\u202f=\u202f0.03). When the experimental scope was extended to 40 strains mainly pharmaceutical related, BCCSA recovered a higher ratio (82% at 24\u202fh incubation, 97% at 48\u202fh) than BCSA (67% at 24\u202fh, 90% at 48\u202fh). It has been confirmed that the test Bcc strains exhibited higher growth rates in BCCSA by growth curve analysis (<jats:italic>p<\/jats:italic>\u202f=\u202f0.02). For 168 non-Bcc strains, BCSA inhibited 94% of non-Bcc growth, while BCCSA inhibited 90%, with no significant difference.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This novel medium BCCSA demonstrates enhanced efficiency and comparable selectivity in detecting Bcc in contrast to BCSA, rendering it more suitable for risk identification of Bcc in samples during pharmaceutical manufacturing process.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2025.1631983","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T05:45:37Z","timestamp":1756446337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A new selective culture medium for isolation of Burkholderia cepacia complex in pharmaceutical industry"],"prefix":"10.3389","volume":"16","author":[{"given":"Meng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e26720","DOI":"10.7759\/cureus.26720","article-title":"Sphingomonas paucimobilis septic shock in an immunocompetent patient","volume":"14","author":"Alkhatib","year":"2022","journal-title":"Cureus."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1099\/ijs.0.02555-0","article-title":"Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov","volume":"53","author":"Coenye","year":"2003","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref4","article-title":"FDA advises drug manufacturers that Burkholderia cepacia complex poses a contamination risk in non-sterile, water-based drug products","year":"2023"},{"key":"ref5","first-page":"579","volume-title":"Bergey's manual of systematic bacteriology","author":"Garrity","year":"2005"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/jcm.22.1.5-8.1985","article-title":"Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis","volume":"22","author":"Gilligan","year":"1985","journal-title":"J. Clin. Microbiol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1128\/jcm.35.3.614-619.1997","article-title":"Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium","volume":"35","author":"Henry","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/JCM.37.4.1004-1007.1999","article-title":"Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis","volume":"37","author":"Henry","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref9","first-page":"383","article-title":"Microbial diversity in pharmaceutical product recalls and environments","volume":"61","author":"Jimenez","year":"2007","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13062-020-0258-5","article-title":"Genome-based classification of Burkholderia cepacia complex provides new insight into its taxonomic status","volume":"15","author":"Jin","year":"2020","journal-title":"Biol. Direct"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.clinmicnews.2016.08.003","article-title":"Burkholderia cepacia: a complex problem for more than cystic fibrosis patients","volume":"38","author":"Landes","year":"2016","journal-title":"Clin. Microbiol. Newsl."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.ajic.2013.01.024","article-title":"An outbreak of burkholderia cenocepacia associated with contaminated chlorhexidine solutions prepared in the hospital","volume":"41","author":"Lee","year":"2013","journal-title":"Am. J. Infect. Control"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1128\/JCM.38.9.3165-3173.2000","article-title":"DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, burkholderia stabilis, and Burkholderia cepacia genomovars i and iii","volume":"38","author":"Mahenthiralingam","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrmicro1085","article-title":"The multifarious, multireplicon Burkholderia cepacia complex","volume":"3","author":"Mahenthiralingam","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/microorganisms9122604","article-title":"Evaluation of three culture media for isolation of Burkholderia cepacia complex from respiratory samples of patients with cystic fibrosis","volume":"9","author":"Marrs","year":"2021","journal-title":"Microorganisms"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1007\/s00203-022-02778-0","article-title":"Burkholderia orbicola sp. Nov., a novel species within the Burkholderia cepacia complex","volume":"204","author":"Morales-Ru\u00edz","year":"2022","journal-title":"Arch. Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jhin.2004.09.036","article-title":"Ralstonia pickettii and Burkholderia cepacia complex bloodstream infections related to infusion of contaminated water for injection","volume":"60","author":"Moreira","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"ref19","first-page":"1","volume-title":"Technical report no. 67 exclusion of objectionable microorganisms from nonsterile pharmaceuticals, medical devices, and cosmetics","year":"2014"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/10408398.2011.570463","article-title":"Microbial growth curves: what the models tell us and what they cannot","volume":"51","author":"Peleg","year":"2011","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhin.2010.03.007","article-title":"Sphingomonas paucimobilis: a persistent gram-negative nosocomial infectious organism","volume":"75","author":"Ryan","year":"2010","journal-title":"J. Hosp. Infect."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jhin.2017.09.012","article-title":"Outbreak of burkholderia cepacia pseudobacteraemia caused by intrinsically contaminated commercial 0.5% chlorhexidine solution in neonatal intensive care units","volume":"98","author":"Song","year":"2018","journal-title":"J. Hosp. Infect."},{"key":"ref23","first-page":"42","article-title":"A review of reported recalls involving microbiological control 2004-2011 with emphasis on FDA considerations of\u201cobjectionable organisms\u201d","volume":"15","author":"Sutton","year":"2012","journal-title":"Am. Pharm. Rev."},{"key":"ref3","article-title":"Microbiological quality considerations in non-sterile drug manufacturing: guidance for industry [Internet]","year":"2025"},{"key":"ref24","first-page":"6454","volume-title":"<60> Microbiological examination of nonsterile products-tests for burkholderia cepaica complex","year":"2021"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"126415","DOI":"10.1016\/j.syapm.2023.126415","article-title":"Burkholderia semiarida sp. nov. and Burkholderia sola sp. nov., two novel b. cepacia complex species causing onion sour skin","volume":"46","author":"Velez","year":"2023","journal-title":"Syst. Appl. Microbiol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1046\/j.1365-2672.2003.02054.x","article-title":"Burkholderia cepacia complex genomovars: utilization of carbon sources, susceptibility to antimicrobial agents and growth on selective media","volume":"95","author":"Vermis","year":"2003","journal-title":"J. Appl. Microbiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1128\/jcm.25.9.1730-1734.1987","article-title":"Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis","volume":"25","author":"Welch","year":"1987","journal-title":"J. Clin. Microbiol."}],"updated-by":[{"DOI":"10.3389\/fmicb.2025.1695214","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000}}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1631983\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:14:34Z","timestamp":1759932874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1631983\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":27,"alternative-id":["10.3389\/fmicb.2025.1631983"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1631983","relation":{"correction":[{"id-type":"doi","id":"10.3389\/fmicb.2025.1695214","asserted-by":"object"}]},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"article-number":"1631983"}}